SEC Form D private-offering filing

Optimeos Life Sciences, Inc.

Name: Optimeos Life Sciences, Inc. - new SEC Form D private-offering filing, Princeton, NJ
Published: 2026-06-03

A new SEC Form D private-offering notice from Princeton, NJ, a $2,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Optimeos Life Sciences, Inc. site↗ Verified via SEC Form D

Develops nanoparticle based delivery technology for biologics, peptides, and RNA/DNA therapeutics

Filed 2026-06-03Filed to raise $2,000,000First money in 2026-05-22Raised so far $1,000,000HQ (as filed) Princeton, NJSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified optimeos.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.